oleanolic acid has been researched along with Kaposi Sarcoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albini, A; Barberis, M; Cammarota, R; Lorusso, G; Noonan, DM; Sporn, MB; Vannini, N | 1 |
1 other study(ies) available for oleanolic acid and Kaposi Sarcoma
| Article | Year |
|---|---|
The synthetic oleanane triterpenoid, CDDO-methyl ester, is a potent antiangiogenic agent.
Topics: Angiogenesis Inhibitors; Animals; Cell Division; Cells, Cultured; Collagen; Drug Combinations; Humans; Laminin; Mice; Neoplasms; Oleanolic Acid; Proteoglycans; Sarcoma, Kaposi | 2007 |